Testosterone cypionate recalls
The FDA has published 23 recalls involving Testosterone cypionate since 2013. The latest was reported on 21 May 2025. Most were for sterility. Sun Pharmaceutical Industries has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls23since 2013
Last 12 months0reported
Class I00% of total
Ongoing2latest 21 May 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 21 91%Class III 2 9%
Why testosterone cypionate is recalled
Companies
By year
Ongoing testosterone cypionate recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Testosterone Cypionate Injection, 200 mg/mL, CIII recalled | Empower Clinic Services | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200mg per mL recalledTestosterone Cypionate | Eugia US | Manufacturing (CGMP) Deviations | Nationwide |
All testosterone cypionate recalls, newest first
23 totalShould you stop taking Testosterone cypionate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.